Man Group’s Alignment Healthcare ALHC Stock Holding History

Man Group’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-48,528	Closed	-$571K	–	2060
2022 Q4	$571K	Buy	+48,528	New	+$590K	﹤0.01%	1485

Other funds holding ALHC

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Man Group's ALHC Position: Q1 2023 in Review

Man Group sold out of Alignment Healthcare (ALHC) in Q1 2023, closing a stake of 48,528 shares — an estimated $571K sold.

Man Group first reported a position in ALHC in Q4 2022 and held it in 1 quarter. The position peaked at $571K in Q4 2022. 130 funds tracked by Wall St. Rank hold ALHC as of Q1 2023.

Man Group reported no remaining Alignment Healthcare position as of Q1 2023 after selling out during the quarter.
Man Group sold 48,528 Alignment Healthcare shares in Q1 2023, an estimated $571K.
Man Group first reported a position in Alignment Healthcare in Q4 2022 and held it in 1 quarter.
Man Group's Alignment Healthcare position peaked at $571K in Q4 2022.
130 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.